Parents of infants with neonatal abstinence syndrome (NAS) in the NICU may have
questions about the long-term consequences of prenatal exposure to methadone, both …

Objectives: To evaluate the effects of a multiple daily dose methadone regimen in pregnancy
on neonatal outcomes. Methods: Although methadone maintenance has been the standard …

Neonatal abstinence syndrome (NAS), a clinical condition that has been recognized for over
30 years, remains a significant clinical issue, although our knowledge of abstinence, its …

OBJECTIVE: The objective of the study was to identify maternal variables predicting length
of treatment for neonatal abstinence syndrome (NAS). STUDY DESIGN: This was a …

Maternal tobacco consumption during pregnancy has been associated with lower birth
weight infants, preterm births, intrauterine growth retardation, smaller head circumference …

Objective: Each year in the US∼ 50 000 neonates receive inpatient pharmacotherapy for
the treatment of neonatal abstinence syndrome (NAS). The objective of this study is to …

OBJECTIVE: To estimate the relationship between maternal methadone dose and the
incidence of neonatal abstinence syndrome (NAS). STUDY DESIGN: We performed a …

Abstract Neonatal Abstinence Syndrome (NAS) is one of the primary negative effects of
substance use during pregnancy. The exact statistics regarding NAS and substance use …

Importance Although opioids are used to treat neonatal abstinence syndrome (NAS), the
best pharmacologic treatment has not been established. Objective To compare the safety …

Background Neonatal abstinence syndrome (NAS) occurs following prenatal opioid
exposure. It is characterized by signs and symptoms indicating central nervous system …